Phase I Vaccinia Virus JX-594 for Relapsed/Refractory Neuroblastoma and Other Pediatric Solid Tumors Project Title: Phase I Vaccinia Virus JX-594 for Relapsed/Refractory Neuroblastoma and Other Pediatric Solid Tumors Researcher: Timothy Cripe, […]
Phase I Vaccinia Virus JX-594 for Relapsed/Refractory Neuroblastoma and Other Pediatric Solid Tumors Project Title: Phase I Vaccinia Virus JX-594 for Relapsed/Refractory Neuroblastoma and Other Pediatric Solid Tumors Researcher: Timothy Cripe, […]
Phase I Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors Project Title: Phase I Vinblastine and Sirolimus in Pediatric Patients With Recurrent orRefractory Solid […]
Phase I Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma Project Title: Phase I Combining Decitabine and Vaccine Therapy for Patients With RelapsedNeuroblastoma and SarcomaResearcher: Kenneth […]
Pilot Study of High-Intensity Focused Ultrasound (HIFU) for Unresectable Neuroblastoma Project Title: Pilot Study of High-Intensity Focused Ultrasound (HIFU) for UnresectableNeuroblastomaResearcher: Ted Gerstle, MDInstitution: The Hospital for Sick Children, TorontoStudy […]
Administration of TAA- Specific CTL Immunotherapy for Pediatric Solid Tumors Project Title: Administration of TAA- Specific CTL Immunotherapy for Pediatric Solid TumorsResearcher(s): Ann Leen, MD; Helen Heslop, MDInstitution: Baylor College […]
Optimizing SN22 Nanoparticles to Treat Children with High-Risk Neuroblastomas Project Title: Optimizing SN22 Nanoparticles to Treat Children with High-RiskNeuroblastomas Researcher: Garrett Brodeur, MDInstitution: Children’s Hospital of Philadelphia (CHOP)Study Type: Pre-Clinical […]
GPC2 Directed Immunotherapies for Neuroblastoma and Other Pediatric Cancers Project Title: GPC2 Directed Immunotherapies for Neuroblastoma and Other Pediatric CancersResearcher: Kris Bosse, MDInstitution: Children’s Hospital of Philadelphia (CHOP)Study Type: Preclinical […]